Microbiome diversity in carriers of fluoroquinolone resistant


Journal

Investigative and clinical urology
ISSN: 2466-054X
Titre abrégé: Investig Clin Urol
Pays: Korea (South)
ID NLM: 101674989

Informations de publication

Date de publication:
03 2019
Historique:
received: 04 11 2018
accepted: 03 02 2019
entrez: 7 3 2019
pubmed: 7 3 2019
medline: 10 1 2020
Statut: ppublish

Résumé

Fluoroquinolone-resistant (FQR) We perform an observational study to investigate the microbiome differences in men with and without FQR organisms found on rectal culture. A rectal swab with two culturettes was performed on men before an upcoming prostate biopsy procedure as standard of care to perform "targeted prophylaxis." Detection of FQR was performed by the standard microbiology lab inoculates the swab onto MacConkey agar containing ciprofloxacin. The extra swab was sent for 16S rRNA amplicon sequencing (MiSeq paired-end) using the V1V2 primer. Alpha and beta-diversity analysis were performed using QIIME. We used PERMANOVA to evaluate the statistical significance of beta-diversity distances within and between groups of interest. We collected 116 rectal swab samples before biopsy for 16S rRNA amplicon sequencing. We identified 18 isolates (15.5%, 18/116) that were positive and had relative reduced diversity profiles (p<0.05). Enterobacteriaceae were significantly over-represented in the FQR subjects (adjusted p=0.03). Microbiome analysis determined that men colonized with FQR bacteria have less diverse bacterial communities (dysbiosis), higher levels of Enterobacteriaceae and reduced levels of

Identifiants

pubmed: 30838339
doi: 10.4111/icu.2019.60.2.75
pmc: PMC6397931
doi:

Substances chimiques

Fluoroquinolones 0

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-83

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI104681
Pays : United States

Déclaration de conflit d'intérêts

CONFLICTS OF INTEREST: Resphera Biosciences was paid to perform the microbiome analysis, and Dr. White is the owner of the company.

Références

J Urol. 2014 Dec;192(6):1673-8
pubmed: 24928266
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8922-6
pubmed: 9671780
Nature. 2010 Mar 4;464(7285):59-65
pubmed: 20203603
PLoS One. 2013 Dec 31;8(12):e83823
pubmed: 24391833
Int J Mol Sci. 2018 Nov 22;19(12):
pubmed: 30469463
ILAR J. 2015;56(2):205-17
pubmed: 26323630
Nature. 2017 Jun 22;546(7659):528-532
pubmed: 28614296
PLoS Biol. 2012;10(8):e1001377
pubmed: 22904687
PLoS One. 2014 Jul 14;9(7):e101344
pubmed: 25020051
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2081-5
pubmed: 7892228
Bioinformatics. 2010 Jan 15;26(2):266-7
pubmed: 19914921
Nature. 2011 May 12;473(7346):174-80
pubmed: 21508958
Clin Infect Dis. 2013 Jul;57(2):267-74
pubmed: 23532481
J Urol. 2012 Apr;187(4):1275-9
pubmed: 22341272
Nat Med. 2013 May;19(5):576-85
pubmed: 23563705
J Urol. 2011 Nov;186(5):1830-4
pubmed: 21944136
Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
PLoS One. 2017 Jan 27;12(1):e0170742
pubmed: 28129384
Front Microbiol. 2013 Apr 17;4:87
pubmed: 23616784
Nature. 2012 Jun 13;486(7402):215-21
pubmed: 22699610
mBio. 2014 Jan 07;5(1):e00944-13
pubmed: 24399857
ISME J. 2012 Mar;6(3):610-8
pubmed: 22134646
PLoS One. 2012;7(6):e39315
pubmed: 22720093
Behav Brain Res. 2001 Nov 1;125(1-2):279-84
pubmed: 11682119
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
Clin Infect Dis. 2015 Apr 1;60(7):979-87
pubmed: 25516194
Int J Antimicrob Agents. 2014 Apr;43(4):301-9
pubmed: 24630305
Microbiome. 2018 Apr 20;6(1):73
pubmed: 29678198
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9827-32
pubmed: 8790416

Auteurs

Michael A Liss (MA)

Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.
South Texas Veterans Healthcare System, San Antonio, TX, USA.

Robin J Leach (RJ)

Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.
Department of Cell Systems and Anatomy, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.

Elizabeth Rourke (E)

Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.

Allison Sherrill (A)

Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.

Teresa Johnson-Pais (T)

Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.
Department of Cell Systems and Anatomy, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.

Zhao Lai (Z)

Genome Sequencing Facility (GSF) in the Greehey Children's Cancer Research Institute (Greehey CCRI), San Antonio, TX, USA.

Joseph Basler (J)

Department of Urology, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.

James R White (JR)

Resphera Biosciences, San Antonio, TX, USA.

Jan E Patterson (JE)

Department of Medicine, UT Health San Antonio Long School of Medicine, San Antonio, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH